Swiss Life Asset Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.8M Buy
183,308
+2,964
+2% +$259K 0.07% 205
2026
Q1
$15.4M Buy
180,344
+14,393
+9% +$1.28M 0.08% 208
2025
Q4
$13.1M Sell
165,951
-58,287
-26% -$4.57M 0.07% 220
2025
Q3
$17.9M Buy
224,238
+76,139
+51% +$6.49M 0.09% 167
2025
Q2
$13.5M Buy
148,099
+10,447
+8% +$954K 0.08% 191
2025
Q1
$12.9M Buy
137,652
+22,081
+19% +$1.98M 0.09% 170
2024
Q4
$10.5M Buy
115,571
+16,339
+16% +$1.56M 0.08% 189
2024
Q3
$10.3M Buy
99,232
+2,396
+2% +$244K 0.12% 166
2024
Q2
$9.4M Buy
96,836
+7,515
+8% +$693K 0.11% 168
2024
Q1
$8.04M Sell
89,321
-13,072
-13% -$1.11M 0.11% 166
2023
Q4
$8.17M Buy
102,393
+5,367
+6% +$404K 0.1% 238
2023
Q3
$6.9M Sell
97,026
-2,406
-2% -$180K 0.11% 229
2023
Q2
$7.66M Sell
99,432
-68,840
-41% -$5.33M 0.11% 225
2023
Q1
$12.6M Buy
168,272
+19,689
+13% +$1.46M 0.19% 127
2022
Q4
$11.7M Sell
148,583
-52,116
-26% -$3.91M 0.2% 138
2022
Q3
$14.1M Buy
200,699
+31,655
+19% +$2.48M 0.24% 91
2022
Q2
$13.6M Buy
169,044
+56,115
+50% +$4.39M 0.22% 101
2022
Q1
$8.54M Buy
112,929
+15,371
+16% +$1.22M 0.12% 191
2021
Q4
$8.33M Sell
97,558
-37,267
-28% -$2.91M 0.11% 223
2021
Q3
$10.2M Buy
134,825
+61,433
+84% +$4.88M 0.14% 179
2021
Q2
$7.87M Sell
73,392
-121,140
-62% -$9.91M 0.08% 239
2021
Q1
$15.3M Buy
194,532
+5,935
+3% +$465K 0.22% 105
2020
Q4
$16.1M Buy
188,597
+105,606
+127% +$8.73M 0.24% 93
2020
Q3
$6.39M Buy
82,991
+2,263
+3% +$173K 0.1% 169
2020
Q2
$5.92M Buy
80,728
+33,194
+70% +$2.36M 0.1% 164
2020
Q1
$3.16M Buy
47,534
+5,172
+12% +$365K 0.06% 209
2019
Q4
$2.92M Sell
42,362
-3,506
-8% -$239K 0.06% 272
2019
Q3
$3.37M Sell
45,868
-7,366
-14% -$534K 0.04% 232
2019
Q2
$3.81M Sell
53,234
-4,364
-8% -$310K 0.05% 210
2019
Q1
$3.95M Buy
57,598
+18,635
+48% +$1.2M 0.05% 198
2018
Q4
$2.32M Sell
38,963
-37,721
-49% -$2.36M 0.05% 147
2018
Q3
$5.13M Buy
76,684
+67,577
+742% +$4.5M 0.07% 200
2018
Q2
$590K Sell
9,107
-15,071
-62% -$986K 0.01% 418
2018
Q1
$1.73M Buy
24,178
+12,911
+115% +$929K 0.03% 322
2017
Q4
$851K Buy
11,267
+5,281
+88% +$386K 0.02% 361
2017
Q3
$435K Buy
+5,986
New +$431K 0.01% 385
2016
Q4
Sell
-3,741
Closed -$277K 437
2016
Q3
$277K Buy
+3,741
New +$277K 0.01% 398
2015
Q3
Sell
-32,311
Closed -$2.12M 313
2015
Q2
$2.12M Hold
32,311
0.07% 115
2015
Q1
$2.24M Buy
+32,311
New +$2.23M 0.09% 114

Other funds holding CL

Swiss Life Asset Management's CL Position: Q2 2026 in Review

Swiss Life Asset Management increased its Colgate-Palmolive (CL) stake by 1.6% in Q2 2026, buying an estimated $259K and bringing the position to 183,308 shares worth $16.8M. The position accounts for 0.07% of the portfolio, ranked #205.

Swiss Life Asset Management first reported a position in CL in Q1 2015 and has held it in 39 quarters since. The position peaked at $17.9M in Q3 2025. 1,557 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Swiss Life Asset Management held 183,308 shares of Colgate-Palmolive worth $16.8M as of Q2 2026.
  • Swiss Life Asset Management bought 2,964 Colgate-Palmolive shares in Q2 2026, an estimated $259K.
  • Colgate-Palmolive made up 0.07% of Swiss Life Asset Management's portfolio in Q2 2026, its #205 holding.
  • Swiss Life Asset Management first reported a position in Colgate-Palmolive in Q1 2015 and has held it in 39 quarters since.
  • Swiss Life Asset Management's Colgate-Palmolive position peaked at $17.9M in Q3 2025.
  • 1,557 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.